SCHEMBL6537628

SCHEMBL6537628

Nc1cccc2c(=O)nc[nH]c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.54
IMPDH2 P12268 1/20 0.46
CDK5 Q00535 2/20 0.42
CLK1 P49759 1/20 0.42
CDK5R1 Q15078 1/20 0.42
TDP1 Q9NUW8 3/20 0.42
POLB P06746 2/20 0.42
RECQL P46063 1/20 0.42
ALDH1A1 P00352 3/20 0.39
PDPK1 O15530 1/20 0.39
CA12 O43570 1/20 0.39
ALOX15 P16050 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA9 Q16790 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
ABL1 P00519 2/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
JAK2 O60674 1/20 0.39
PRKD3 O94806 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12042120 0.79 DYRK1A (0.44) PARP1CDK5CLK1CDK5R1ALDH1A1
SCHEMBL15367210 0.79 DYRK1A (0.41) PARP1CDK5CLK1CDK5R1ALDH1A1
SCHEMBL5370069 0.78 PARP1 (0.54) PARP1PDPK1CA12ALOX15SMN1; SMN2
SCHEMBL13857871 0.78 PARP1 (0.39) PARP1CDK5POLBALDH1A1PDPK1
SCHEMBL14854026 0.78 PARP1 (0.54) PARP1CDK5PDPK1CA12ALOX15
SCHEMBL29161408 0.74 ABL1 (0.56) PARP1POLBRECQLALDH1A1SMN1; SMN2
SCHEMBL30734368 0.74 ABL1 (0.56) PARP1POLBRECQLALDH1A1SMN1; SMN2
SCHEMBL5675915 0.73 CLK1 (0.50) PARP1CDK5CLK1CDK5R1TDP1
SCHEMBL30036694 0.72 PARP1 (0.43) PARP1IMPDH2TDP1POLBRECQL
SCHEMBL312428 0.72 PARP1 (0.43) PARP1IMPDH2TDP1POLBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
US-4012371-A Benzinaldazolyl-, quinolonyl-, or phenmorpholonylazo-3-cyano-4-methyl-1,2-[1',2']-benz-[4',5']-imidazolo-6-hydroxypyridine colorants CIBA-GEIGY CORPORATION (US) 1977-03-15 US disclosed